Beckman Coulter Licenses HCV Technology for MDx Use | GenomeWeb
NEW YORK (GenomeWeb News) – Beckman Coulter said today that it has licensed certain rights to hepatitis C virus testing from Siemens Healthcare Diagnostics.
 
Beckman said that under the agreement it received rights to develop, manufacture, and sell a quantitative viral load HCV blood test for use on a molecular diagnostics instrument. The firm is developing a next-generation molecular diagnostics platform, called the UniCel DxN, which it plans to launch in 2010.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.